Advertisement

Does Lithium Carbonate Therapy for Alcoholism Deter Relapse Drinking?

Chapter
Part of the Recent Developments in Alcoholism book series (RDIA, volume 7)

Abstract

In order to test the efficacy of lithium therapy for alcoholism, to test whether lithium therapy reduces depressive symptoms among alcoholics, and to test whether any positive lithium treatment effects are associated with an antidepressant action, we undertook a double-blind placebo-controlled study of 122 patients meeting DSM-III criteria for alcohol dependence and hospitalized for alcoholism rehabilitation. We used survival analysis to examine the cumulative proportion of each treatment group that remained abstinent (i. e., “survived”) over the course of 18 months, using complete abstinence from alcohol as the principal outcome measure.

Our findings add support to the hypothesis that lithium carbonate promotes abstinence from alcohol and delays the time to first drink. Patients treated with lithium were much less likely to be rehospitalized for alcoholism rehabilitation during the 18-month follow-up. These effects did not appear to be related to the treatment of concomitant or underlying affective symptoms. We found no support, on the other hand, for the hypothesis that lithium therapy reduces the frequency of drinking for relapse drinkers.

Keywords

Affective Disorder Abstinence Rate Lithium Therapy Global Assessment Scale High Blood Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kline NS, Wren JC, Cooper TB, Varga E, Canal O: Evaluation of lithium therapy in chronic and periodic alcoholism. Am J Med Sci 268: 15–20, 1974.PubMedCrossRefGoogle Scholar
  2. 2.
    Wren JC, Kline NS, Cooper TB, Varga E, Canal O: Evaluation of lithium therapy in chronic alcoholism. Clin Med 81: 33–36, 1974.Google Scholar
  3. 3.
    Flemenbaum A: Affective disorders and “chemical dependence”: Lithium for alcohol and drug addiction? Dis Nerv Syst 35: 281–285, 1974.PubMedGoogle Scholar
  4. 4.
    Merry J, Reynolds CM, Bailey J, Coppen A: Prophylactic treatment of alcoholism by lithium carbonate. Lancet 2: 481–482, 1976.CrossRefGoogle Scholar
  5. 5.
    Young LD, Keeler MH, Martin M: Sobering data in lithium in alcoholism. Lancet 1: 144, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Crane DL: Manic depressive disease in alcoholism, in Seixas FA (ed): Currents in Alcoholism, Vol. 2. New York, Grune and Stratton, 1977, pp 53–58.Google Scholar
  7. 7.
    Ho AD, Tsai CS: Effects of lithium on alcohol preference and withdrawal. Ann NY Acad Sci 273: 371–377, 1976.PubMedCrossRefGoogle Scholar
  8. 8.
    Judd LL, Huey LY: Lithium antagonizes ethanol intoxication in alcoholics. Am J Psychiatry 141: 1517–1521, 1984.PubMedGoogle Scholar
  9. 9.
    Moos RH, Finney JW: The expanding scope of alcoholism treatment evaluation. Am Psychol 38: 1036–1044, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Fuller RK, Williford WO: Life-table analysis of abstinence in a study evaluating the efficacy of disulfiram. Alcohol Clin Exp Res 4: 298–301, 1980.PubMedCrossRefGoogle Scholar
  11. 11.
    Poikolainen K: Survival methods in the evaluation of the outcome of alcoholism treatment. Br J Addictions 78: 403–407, 1983.CrossRefGoogle Scholar
  12. 12.
    Hollingshead AD: Four Factor Index of Social Status. Unpublished data, 1975.Google Scholar
  13. 13.
    Fawcett J, Clark DC, Gibbons RD, Aagesen CA, Pisani V, Tilkin JM, Sellers D, Stutzman D: Evaluation of lithium therapy for alcoholism. J Clin Psychiatry 45: 494–499, 1984.PubMedGoogle Scholar
  14. 14.
    Fawcett J, Clark DC, Aagesen CA, Pisani VD, Tilkin JM, Sellers D, McGuire M, Gibbons RD: A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Arch Gen Psychiatry 44: 248–256, 1987.PubMedCrossRefGoogle Scholar
  15. 15.
    Endicott J, Spitzer R: A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 33: 766–771, 1976.PubMedCrossRefGoogle Scholar
  16. 16.
    Spitzer R, Endicott J, Robins E: Research Diagnostic Criteria: Rationale and reliability. Arch Gen Psychiatry 35: 773–782, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Andreasen NC, Endicott J, Spitzer RL, Winokur G: The family history method using diagnostic criteria. Arch Gen Psychiatry 34: 1229–1235, 1977.PubMedCrossRefGoogle Scholar
  18. 18.
    Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62, 1960.PubMedCrossRefGoogle Scholar
  19. 19.
    Endicott J, Nee J, Fleiss J, et al: Hamilton Depression Rating Scale: Extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 8: 98–103, 1981.CrossRefGoogle Scholar
  20. 20.
    Beck A, Beamesderfer A: Assessment of depression: The Depression Inventory. Mod Probl Pharmacopsychiatry 7: 151–169, 1974.PubMedGoogle Scholar
  21. 21.
    Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33: 766–771, 1976.PubMedCrossRefGoogle Scholar
  22. 22.
    Weissman MM, Bothwell S: Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 33: 1111–1115, 1976.PubMedCrossRefGoogle Scholar
  23. 23.
    Shipley W: A self-administering scale for measuring intellectual impairment and deterioration. J Psychol 9: 371–377, 1940.CrossRefGoogle Scholar
  24. 24.
    Paulson M, Lin T: Predicting WAIS IQ from Shipley-Hartford scores. J Clin Psychol 29: 1–9 (monograph Suppl), 1970.CrossRefGoogle Scholar
  25. 25.
    Andreasen N, Grove W, Shapiro R, et al: Reliability of lifetime diagnosis: A multicenter collaborative perspective. Arch Gen Psychiatry 38: 400–405, 1981.PubMedCrossRefGoogle Scholar
  26. 26.
    Keller MB, Lavori PW, Andreasen NC, Grove WM, Shapiro RW, Scheftner W, McDonald-Scott P: Test-related reliability of assessing psychiatrically ill patients in a multi-center design. J Psychiatr Res 16: 213–227, 1981.PubMedCrossRefGoogle Scholar
  27. 27.
    Keller M, Lavori P, McDonald-Scott P, et al: Reliability of lifetime diagnoses and symptoms in patients with a current affective disorder. J Psychiatr Res 16: 229–240, 1981.PubMedCrossRefGoogle Scholar
  28. 28.
    Breslow N: A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57: 579–594, 1970.CrossRefGoogle Scholar
  29. 29.
    Robins E, Munoz RA, Marten S, Gentry KA: Primary and secondary affective disorders, in Zubin J, Freyman FA (eds): Disorders of Mood. Baltimore, John Hopkins University Press, 1972.Google Scholar
  30. 30.
    McClellan AT, Luborsky L, Woody GE, et al: Predicting response to alcoholic and drug abuse treatments: Role of psychiatric severity. Arch Gen Psychiatry 40: 620–625, 1983.CrossRefGoogle Scholar
  31. 31.
    Sackett DL, Gent M: Controversy in counting and attributing events in clinical trials. N Engl J Med 301: 1410–1412, 1979.PubMedCrossRefGoogle Scholar
  32. 32.
    Jerram TC, McDonald R: Plasma lithium control with particular reference to minimum effective levels, in Johnson FN, Johnson S (eds): Lithium in Medical Practice: Proceedings of the First British Lithium Congress. Baltimore, University Park Press, 1980, pp 243–247.Google Scholar
  33. 33.
    Hullin RP: Minimum serum lithium levels for effective prophylaxis, in Johnson FN (ed): Handbook of Lithium Therapy. Baltimore, University Park Press, 1980, pp 243–247.CrossRefGoogle Scholar
  34. 33.
    O’Sullivan K, Whillans P, Daley M, Caroll B, Clare A, Conney J: A comparison of alcoholics with and without effective disorder. Br J Psychiatry 143: 133–138, 1983.PubMedCrossRefGoogle Scholar
  35. 34.
    Miller WR, Hester RK: Inpatient alcoholism treatment: Who benefits? Am Psycholo 41: 794–805, 1986.CrossRefGoogle Scholar
  36. 35.
    Kofoed LL: Chemical monitoring of disulfiram compliance: A study of alcoholic outpatients. Alcohol Clin Exp Res 11: 481–485, 1987.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  1. 1.Department of PsychiatryRush-Presbyterian-St. Luke’s Medical CenterChicagoUSA

Personalised recommendations

Cite chapter

Buy options